Clinical trials
Phase 3 Polycythemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AOP Orphan Pharmaceuticals AG | 2 |
| Baylor College of Medicine | 1 |
| Consorzio Mario Negri Sud | 1 |
| Geron Corporation | 1 |
| PharmaEssentia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycythemia | 6 |
| Polycythemia Vera | 4 |
| Myeloproliferative Disorders | 3 |
| Bone Marrow Diseases | 2 |
| Hematologic Diseases | 2 |
| Primary Myelofibrosis | 1 |
| Thrombocythemia, Essential | 1 |
| Thrombocytosis | 1 |
| Thrombosis | 1 |
Trials
Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.